Probiotics in functional bowel disorders - PubMed

Review

Probiotics in functional bowel disorders

Keren Hod et al. Best Pract Res Clin Gastroenterol. 2016 Feb.

Abstract

Functional bowel disorders (FBDs) are the most common gastrointestinal (GI) disorders seen by gastroenterologists and primary care physicians. The disorders affect patients functioning and quality of life (QOL) and are associated with significant healthcare burden. The current theory regarding the development of FBDs suggests brain-gut axis dysfunctions associated abnormal GI motility and sensation. Recent data suggest that alterations in the intestinal microbiota may have a role in the pathogenesis of FBDs; or at least have the potential to affect intestinal functions that are thought to be relevant to the development of functional GI symptoms. This has led to growing interest of healthcare providers and patients in targeting the intestinal microbiota for the treatment of FBDs. In this article we discuss the potential role probiotic interventions in the treatment of FBDs. We review the evidence from pre-clinical and clinical studies and discuss the current recommendations for the use of probiotics for FBDs in clinical practice.

Keywords: Functional bowel disorders; Intestinal mocrobiota; Irritable bowel syndrome; Probiotics.

Similar articles

• The Gut Microbiome in Irritable Bowel Syndrome and Other Functional Bowel Disorders.

  Ringel Y. Ringel Y. Gastroenterol Clin North Am. 2017 Mar;46(1):91-101. doi: 10.1016/j.gtc.2016.09.014. Gastroenterol Clin North Am. 2017. PMID: 28164856 Review.

• Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.

  Harris LA, Baffy N. Harris LA, et al. Postgrad Med. 2017 Nov;129(8):872-888. doi: 10.1080/00325481.2017.1383819. Epub 2017 Oct 13. Postgrad Med. 2017. PMID: 28936910 Review.

• The Intestinal Microbiota and Irritable Bowel Syndrome.

  Ringel Y, Ringel-Kulka T. Ringel Y, et al. J Clin Gastroenterol. 2015 Nov-Dec;49 Suppl 1:S56-9. doi: 10.1097/MCG.0000000000000418. J Clin Gastroenterol. 2015. PMID: 26447966

• Irritable bowel syndrome, the microbiota and the gut-brain axis.

  Raskov H, Burcharth J, Pommergaard HC, Rosenberg J. Raskov H, et al. Gut Microbes. 2016 Sep 2;7(5):365-83. doi: 10.1080/19490976.2016.1218585. Epub 2016 Jul 29. Gut Microbes. 2016. PMID: 27472486 Free PMC article. Review.

• Treating irritable bowel syndrome with probiotics: the evidence.

  Parkes GC, Sanderson JD, Whelan K. Parkes GC, et al. Proc Nutr Soc. 2010 May;69(2):187-94. doi: 10.1017/S002966511000011X. Epub 2010 Mar 18. Proc Nutr Soc. 2010. PMID: 20236566 Review.

Cited by

• The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.

  Sun YY, Li M, Li YY, Li LX, Zhai WZ, Wang P, Yang XX, Gu X, Song LJ, Li Z, Zuo XL, Li YQ. Sun YY, et al. Sci Rep. 2018 Feb 14;8(1):2964. doi: 10.1038/s41598-018-21241-z. Sci Rep. 2018. PMID: 29445178 Free PMC article. Clinical Trial.

• Meta-analysis of the efficacy of probiotics to treat diarrhea.

  Wang F, Zhao T, Wang W, Dai Q, Ma X. Wang F, et al. Medicine (Baltimore). 2022 Sep 23;101(38):e30880. doi: 10.1097/MD.0000000000030880. Medicine (Baltimore). 2022. PMID: 36197181 Free PMC article.

• Positive clinical outcomes derived from using Streptococcus salivarius K12 to prevent streptococcal pharyngotonsillitis in children: a pilot investigation.

  Di Pierro F, Colombo M, Zanvit A, Rottoli AS. Di Pierro F, et al. Drug Healthc Patient Saf. 2016 Nov 21;8:77-81. doi: 10.2147/DHPS.S117214. eCollection 2016. Drug Healthc Patient Saf. 2016. PMID: 27920580 Free PMC article.

• Fecal Microbiota and Diet of Children with Chronic Constipation.

  de Moraes JG, Motta ME, Beltrão MF, Salviano TL, da Silva GA. de Moraes JG, et al. Int J Pediatr. 2016;2016:6787269. doi: 10.1155/2016/6787269. Epub 2016 Jun 23. Int J Pediatr. 2016. PMID: 27418934 Free PMC article.

• Lactobacillus casei and Epidermal Growth Factor Prevent Osmotic Stress-Induced Tight Junction Disruption in Caco-2 Cell Monolayers.

  Samak G, Rao R, Rao R. Samak G, et al. Cells. 2021 Dec 18;10(12):3578. doi: 10.3390/cells10123578. Cells. 2021. PMID: 34944085 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science

• Other Literature Sources

  • scite Smart Citations